Vincent Bouchiat | Grapheal: Why does the polycrystalline nature of CVD graphene cause a massive 4x variation in biosensor sensitivity?
17:16 - 18:31
Other snippets from this talk
Summary of the clip:
Why does the polycrystalline nature of CVD graphene cause a massive 4x variation in biosensor sensitivity?
One of the most persistent bottlenecks in transitioning graphene from the lab to commercial production is the wide spread of device-to-device sensitivity. Even when exposed to identical analyte solutions under controlled conditions, individual sensors fabricated from the same batch can exhibit a four-fold difference in electrical response.
This variation is fundamentally linked to the polycrystalline structure of large-scale CVD graphene when transferred onto polymer films. The presence of grain boundaries, atomic defects, and transfer-induced wrinkles alters the local charge carrier mobility and surface chemistry, creating non-uniform sensing regions.
Overcoming this challenge requires rigorous process control and standardization during the transfer and functionalization phases. Narrowing down this sensitivity distribution is the premier engineering hurdle that must be resolved to achieve reliable, high-yield manufacturing of diagnostic devices.
In this short video, you can learn:
* The underlying physical causes of the high sensitivity variance in CVD graphene sensors.
* How grain boundaries and lattice defects on polymers impact electrical response consistency.
* Why process rationalization is critical for the commercial upscaling of 2D material biosensors.
📋 **Clip Abstract** This clip addresses the critical manufacturing challenge of sensitivity variation in polycrystalline CVD graphene biosensors. It explains how defects and grain boundaries alter electronic behavior and outlines why narrowing this distribution is key to successful industrial scale-up.
#CVDGraphene, #GrapheneBiosensors, #PolycrystallineGraphene, #GrainBoundaries, #FlexibleElectronics, #Bioelectronics
This is a highlight of the presentation:
More Highlights from the same talk.
07:04 - 08:00
How do you transfer monolayer CVD graphene to polymers without leaving toxic metallic residues?
How do you transfer monolayer CVD graphene to polymers without leaving toxic metallic residues?
The industrialization of graphene biosensors hinges on the ability to transfer high-quality monolayer graphene from its growth substrate to flexible, biocompatible carriers. Grapheal's core technology solves this with a high-yield transfer method that starts by depositing a polymer directly on top of chemical vapor deposition (CVD) graphene grown on copper foil.
Once the polymer layer is secured, the underlying copper foil is removed via chemical etching or mechanical delamination. The remaining polymer-graphene stack is inverted, thoroughly rinsed, and treated to eliminate any trace metallic residues that could compromise the biocompatibility or electrical performance of the sensor.
The final output is a flexible, transparent, and highly conductive film. This engineered material functions as a probing electrode, allowing multi-channel biosensing elements to be directly integrated into smart bandages and diagnostic test strips.
In this short video, you can learn:
* The precise step-by-step method of transferring CVD graphene to polymer substrates.
* How chemical etching and delamination are utilized to isolate the graphene-polymer stack.
* Why eliminating metallic residues is critical for maintaining sensor biocompatibility.
📋 **Clip Abstract** This clip details Grapheal's proprietary high-yield process for transferring CVD monolayer graphene onto flexible polymers. It explains how removing metallic impurities yields a highly conductive, biocompatible material suitable for multi-channel medical biosensors.
#CVDGrapheneTransfer, #GrapheneOnPolymer, #MetalFreeDelamination, #BiocompatibleGraphene, #FlexibleBiosensors, #WearableElectronics
14:30 - 15:26
Can we build digital diagnostic tests that run completely battery-free and generate zero electronic waste?
Can we build digital diagnostic tests that run completely battery-free and generate zero electronic waste?
Integrating wireless communication with disposable medical sensors presents a major design challenge due to the environmental and financial cost of batteries. Grapheal addresses this by co-designing the embedded electronics to minimize component count, target a low bill-of-materials, and reduce potential e-waste.
For rapid saliva screening, the system operates entirely battery-free. The diagnostic strip harvests all necessary operational power directly from the radio frequency field generated by a user's NFC-enabled smartphone.
For applications requiring continuous tracking, such as wound care monitoring over multiple days, a different approach is needed. In these scenarios, the patches leverage a specialized bio-sourced energy source that provides sustained power without utilizing toxic chemicals or heavy metals.
In this short video, you can learn:
* The design philosophy behind minimizing electronic waste in disposable biosensors.
* How NFC technology enables completely battery-free digital diagnostic test strips.
* The distinction between passive smartphone-powered tests and bio-sourced energy patches.
📋 **Clip Abstract** This clip explores how Grapheal integrates NFC technology to power digital graphene biosensors without traditional batteries. It highlights the use of RF energy harvesting for rapid testing and bio-sourced power for long-term wound monitoring.
#GrapheneBiosensors, #RFEnergyHarvesting, #BioSourcedPower, #NFCDiagnostics, #PrintedElectronics, #WearableDiagnostics